CME Group Inc. $CME Shares Purchased by Siemens Fonds Invest GmbH

Siemens Fonds Invest GmbH lifted its holdings in CME Group Inc. (NASDAQ:CME) by 20.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 14,786 shares of the financial services provider’s stock after acquiring an additional 2,525 shares during the period. Siemens Fonds Invest GmbH’s holdings in CME Group were worth $4,078,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in the business. Empowered Funds LLC boosted its position in CME Group by 11.5% during the 1st quarter. Empowered Funds LLC now owns 10,027 shares of the financial services provider’s stock worth $2,660,000 after purchasing an additional 1,037 shares during the period. Marshall Wace LLP raised its position in CME Group by 103.1% in the second quarter. Marshall Wace LLP now owns 3,692 shares of the financial services provider’s stock valued at $1,018,000 after purchasing an additional 121,707 shares during the period. Federated Hermes Inc. lifted its stake in shares of CME Group by 1,325.2% during the second quarter. Federated Hermes Inc. now owns 23,572 shares of the financial services provider’s stock worth $6,497,000 after purchasing an additional 21,918 shares in the last quarter. Nebula Research & Development LLC purchased a new stake in shares of CME Group in the second quarter worth about $992,000. Finally, The Manufacturers Life Insurance Company boosted its position in shares of CME Group by 2.6% in the second quarter. The Manufacturers Life Insurance Company now owns 287,876 shares of the financial services provider’s stock worth $79,344,000 after buying an additional 7,397 shares during the period. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Insiders Place Their Bets

In other news, insider Hilda Harris Piell sold 5,753 shares of the business’s stock in a transaction dated Monday, May 18th. The shares were sold at an average price of $304.63, for a total value of $1,752,536.39. Following the completion of the sale, the insider owned 27,702 shares of the company’s stock, valued at approximately $8,438,860.26. The trade was a 17.20% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Terrence A. Duffy sold 35,000 shares of the company’s stock in a transaction dated Friday, May 15th. The shares were sold at an average price of $298.51, for a total transaction of $10,447,850.00. Following the completion of the sale, the chief executive officer owned 55,630 shares in the company, valued at approximately $16,606,111.30. This trade represents a 38.62% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 0.30% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the company. Deutsche Bank Aktiengesellschaft reduced their price target on CME Group from $342.00 to $322.00 and set a “buy” rating on the stock in a research report on Thursday, April 23rd. Argus reiterated a “hold” rating on shares of CME Group in a research note on Wednesday, March 4th. Jefferies Financial Group reduced their target price on shares of CME Group from $356.00 to $349.00 and set a “buy” rating on the stock in a research report on Thursday, April 9th. JPMorgan Chase & Co. raised their price target on shares of CME Group from $266.00 to $271.00 and gave the company an “underweight” rating in a report on Thursday, April 16th. Finally, Piper Sandler reaffirmed an “overweight” rating and set a $329.00 price target on shares of CME Group in a research note on Monday. Eleven equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $305.71.

CME Group Price Performance

Shares of NASDAQ CME opened at $261.60 on Wednesday. CME Group Inc. has a fifty-two week low of $244.56 and a fifty-two week high of $329.16. The business has a 50 day moving average price of $283.14 and a two-hundred day moving average price of $287.95. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The firm has a market cap of $94.79 billion, a PE ratio of 22.32, a price-to-earnings-growth ratio of 2.97 and a beta of 0.21.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.11 by $0.25. The company had revenue of $1.88 billion for the quarter, compared to analyst estimates of $1.77 billion. CME Group had a return on equity of 15.42% and a net margin of 63.19%.CME Group’s quarterly revenue was up 14.5% on a year-over-year basis. During the same period in the prior year, the company posted $2.80 EPS. Sell-side analysts expect that CME Group Inc. will post 12.28 earnings per share for the current fiscal year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Tuesday, June 9th will be issued a $1.30 dividend. The ex-dividend date of this dividend is Tuesday, June 9th. This represents a $5.20 annualized dividend and a yield of 2.0%. CME Group’s dividend payout ratio is currently 44.37%.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.